Top 10 manufacturers in Cefazolin Sodium Market
Updated 09:00:21 January 22, 2020
Prof Resear published a new Market report on Cefazolin Sodium Market. It present the largest 10 manufacruers in Cefazolin Sodium Market. The report is a professional and in-depth study on the current state of the global Cefazolin Sodium market with a focus on the Chinese market. The report provides key statistics on market of Cefazolin Sodium. It is a valuable source of guidance and direction for companies and individuals interested in Cefazolin Sodium industry.
.
Acs Dobfar Spa
Ref A: CE0C9F0B878F437D9CC0C895744BC5AB Ref B: SJCEDGE0214 Ref C: 2020-01-22T13:00:04Z
Fresenius Kabi Anti-Infectives
Ref A: FB1B55A766514F9CB8D962D50F0E8956 Ref B: SJCEDGE0421 Ref C: 2020-01-22T13:00:07Z
Olon
Ref A: 7D2326CFE7B3401395B030964D114E42 Ref B: SJCEDGE0421 Ref C: 2020-01-22T13:00:09Z
Orchid
Ref A: AF237F8365E94BF48BE1FB7C4F7D9966 Ref B: SJCEDGE0207 Ref C: 2020-01-22T13:00:10Z
HPGC
Ref A: 542EE51FD62843E396931E613FF5CC87 Ref B: SJCEDGE0215 Ref C: 2020-01-22T13:00:13Z
CSPC
Ref A: 3888F65DB2BE4B9097096C0CC72B9724 Ref B: SJCEDGE0207 Ref C: 2020-01-22T13:00:15Z
NCPC
Ref A: C0940D3075C3468BA16087DDFA56015D Ref B: SJCEDGE0420 Ref C: 2020-01-22T13:00:17Z
LKPC
Home > About Lkpc > Company > COMPANY PROFILE Shandong Lukang Pharmaceutical Co., Ltd. (hereafter referred to as Lukang Pharma), found in 1966 in Jining, Shandong Province, is a state-owned large-scale comprehensive pharmaceutical enterprise, which was listed on the main board in 1997(stock abbreviation: Lukang Pharma, stock No.: 600789). LKPC .HR - key executives, insider trading, ownership, revenue and average growth rates. Detailed company description & address for Luka Ploce d.d.. DOW JONES, A NEWS CORP COMPANY. News Corp is a network of leading companies in the worlds of diversified media, news, education, and information services. Company profile for Luka Ploce d.d. including key executives, insider trading, ownership, revenue and average growth rates. View detailed LKPC .HR description & address.
Qilu Antibiotics Pharmaceutical
Ref A: 3FCEAB5F29104C21B1168622A309D841 Ref B: SJCEDGE0412 Ref C: 2020-01-22T13:00:20Z
Huarun Jiuxin
Ref A: CB9AB2B20D6C4052994AB09CFA472E29 Ref B: SJCEDGE0418 Ref C: 2020-01-22T13:00:21Z